Analyst says Varian shares will climb:
This article was originally published in Clinica
Initiating coverage on Varian Medical Systems, analysts Deutsche Banc Alex Brown say that the company's share price will climb from its present $60 to $74 within 12 months. The analysts said that Varian's Intensity Modulated Radiation Therapy (IMRT) technology "represents a revolutionary breakthrough that promises to have a profound impact not just on the growth of the radiation therapy market, but more importantly, on patient care".
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.